TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
ANL

Adlai Nortye Ltd.

Healthcare · Biotechnology

15.40$ +1.9% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

Adlai Nortye Ltd. (ANL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 248 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ANL
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
130 130 108 108 71 71 72 72 34 34 248 248
101 101 100 100 64 64 65 65 27 27 241 241
91 91 98 98 61 61 44 44 8.1 8.1 133 133
99 99 98 98 61 – 44 44 9.0 – 233 233
– – 0.4 2.3 – – 1.2 3.1 – – 0.3 0.3
0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
55 51 54 54 46 46 64 64 43 43 34 34
50 50 54 54 45 45 64 64 42 42 25 25
31 30 40 39 27 – 44 44 25 – 18 18
14 14 11 11 10 10 9.7 9.7 13 13 4.6 4.6
– – – – – – – – – – – 7.3
75 79 53 53 25 25 7.9 7.9 -8.3 -8.3 215 215
-377 -373 -401 -401 -429 -429 -448 -448 -465 -465 -470 -470
6.8 20 8.7 8.7 – 111 – 111 11 120 16 16

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?